Table 3.
Values of model parameters estimated by fitting the model to protocol 2 kinetic data from individual lungs in the absence or presence of verapamil in the perfusate
| P1S1, mL/min | P2S2, mL/min | Kpgp, mL/min | k̄2, mL/min | k−2, min−1 | Kd3 | Δψm, mV | CV, % | |
|---|---|---|---|---|---|---|---|---|
| R6G | 48.56 ± 1.03 | 0.75 ± 0.09 | 5.77 ± 0.50 | 11.25 ± 0.67 | 0.117 ± 0.007 | 0.030 ± 0.004 | −117.5 ± 0.3 | 10.2 ± 1.1 |
| R6G + verapamil | 46.54 ± 0.35 | 1.07 ± 0.19 | 0 | 6.90 ± 0.45* | 0.178 ± 0.023* | 0.018 ± 0.003* | −131.2 ± 5.8 | 9.3 ± 0.4 |
Values are means ± SE (n = 6 and 5 without and with verapamil, respectively). Kd1 (%BSA) was fixed at the value in Table 2. CV, coefficient of variation; R6G, rhodamine 6G.
Different from without verapamil (t test, P < 0.05).